I have a three-page handout I give to women who want to try testosterone. It exists because there is no other way to do this. It tells them that the medication I am prescribing has no FDA-approved version for their sex, anywhere in this country. It tells them insurance will almost certainly not cover it, and to budget roughly $130 out of pocket. It tells them to ignore the instructions printed on the pharmacy label, because those instructions were written for a 200-pound man and following them would deliver roughly ten times the dose I intend. It tells them to squeeze out a pea-sized amount of gel — about half a gram — from a packet designed to be emptied in one application, and to make that packet last ten days.

I've been practicing medicine for over two decades. I've sat with women in clinic, on hospital floors, and now through telehealth — and I can tell you that one of the most common moments I witness is this: a woman describes months of fragmented sleep, hot flashes at 2 a.m., anxiety that arrived out of nowhere, a fog that won't lift — and then adds, almost apologetically, "But I'm afraid of hormones." That fear is real, and it didn't come from nowhere. It came from a 2002 study that made headlines around the world and led millions of women to stop — or never start — hormone therapy. What those headlines missed, and what took two more decades of research to fully untangle, is that not all hormones behave the same way in your body. The type matters enormously.

Oxytocin is a nine–amino-acid peptide hormone produced in the hypothalamus and released by the posterior pituitary gland. Most of us learned about it in two contexts: labor and breastfeeding. Synthetic oxytocin (Pitocin) has been used clinically for more than fifty years to induce contractions and support milk letdown. What we didn't learn in medical school is that oxytocin receptors are found throughout the body — in the brain, the cardiovascular system, the gut, the bones, the skin, and the vaginal epithelium. This receptor distribution is the reason oxytocin has been investigated for an unusually wide range of conditions: chronic pain, social anxiety, postpartum depression, autism spectrum traits, gastroparesis, weight regulation, and — most relevant to us — sexual function and vaginal tissue health in women.

Osteoporosis is often called “the silent thief” because it steals bone density without warning — no pain, no symptoms, and no red flags — until a fracture occurs. Despite affecting over 200 million people worldwide and causing more than 8.9 million fractures annually, our screening guidelines remain reactive rather than proactive, particularly for women under 65 who carry significant risk factors. As clinicians, we must ask ourselves: are we waiting too long to look?

If you’re a woman in your late thirties or forties experiencing mood swings, brain fog, weight gain, insomnia, crushing fatigue, or a vanishing libido, you’ve probably been told one of two things: “It’s just stress,” or “You’re too young for menopause.” As a clinician who works with women navigating the perimenopause transition every day, I want to be clear: that advice is outdated, and it is leaving millions of women suffering unnecessarily. The research is catching up to what many of us are seeing in practice—and what women have been telling us about their own bodies for years.